Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Plus Therapeutics ( (PSTV) ) is now available.
On March 20, 2026, Plus Therapeutics, Inc. appointed industry veteran Ronald A. Andrews as an independent director to its board, filling the vacancy created by the resignation of Dr. Robert Lenk, who left without any disagreement over the company’s operations or policies. Andrews, a seasoned leader in diagnostics and molecular diagnostics with more than 35 years of experience at firms including Twin Strand Biosciences, Oncocyte, and Thermo Fisher Scientific, also joined the Nominating and Corporate Governance Committee and will receive standard non-employee director compensation and indemnification, signaling the company’s intent to strengthen its governance and strategic expertise in advanced diagnostic markets.
The most recent analyst rating on (PSTV) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Plus Therapeutics stock, see the PSTV Stock Forecast page.
Spark’s Take on PSTV Stock
According to Spark, TipRanks’ AI Analyst, PSTV is a Neutral.
The score is primarily held down by weak financial performance (zero revenue in 2025, widening losses, and accelerating cash burn). Technicals also remain soft with the stock below key longer-term moving averages. A positive corporate strategy update provides some support, but valuation is constrained by ongoing unprofitability.
To see Spark’s full report on PSTV stock, click here.
More about Plus Therapeutics
Plus Therapeutics, Inc. operates in the healthcare sector, focusing on therapeutic innovation, and is governed by a board that adheres to Nasdaq listing standards and the company’s corporate governance guidelines. The company utilizes independent directors and specialized committees, such as its Nominating and Corporate Governance Committee, to oversee governance and strategic direction in line with public company best practices.
Average Trading Volume: 9,542,405
Technical Sentiment Signal: Sell
Current Market Cap: $42.18M
Find detailed analytics on PSTV stock on TipRanks’ Stock Analysis page.